News.

Glenn Frommer joins SBN Board, PKD Advocate and Investor

Glenn Frommer joins SBN Board, PKD Advocate and Investor

Santa Barbara, CA, USA  |  April 27, 2023 Santa Barbara Nutrients (SBN) is delighted to announce the appointment of Mr. Glenn Frommer to SBN’s Board of Directors which expands the Board to five members. Glenn will leverage the experience from his nearly 40 years of...

Patent Awarded in Mexico for Science Underlying KetoCitra

Patent Awarded in Mexico for Science Underlying KetoCitra

Santa Barbara Nutrients’ Scientists Awarded Breakthrough Patent in Mexico Related to Polycystic Kidney Disease (PKD) Santa Barbara, California – December 11th, 2022 The patented technology was initially developed by Dr. Weimbs and Dr. Torres at the University of...

Fran Towey, former CEO of Fullscript, Joins SBN’s Advisory Board

Fran Towey, former CEO of Fullscript, Joins SBN’s Advisory Board

Santa Barbara Nutrients announces new advisory board member, Fran Towey, former CEO of Fullscript We are committed to Empowering people to advocate for their health and raise awareness for those living with kidney disease. Santa Barbara, California – April 27th, 2022...

Dr. Chris Leamon joins SBN’s Advisory Board

Dr. Chris Leamon joins SBN’s Advisory Board

Santa Barbara Nutrients announces new advisory board member, Dr. Chris Leamon, leader in pharmaceutical research Santa Barbara, California – March 23rd, 2022 Facebook Linkedin Twitter Instagram Youtube Santa Barbara Nutrients (SBN) is pleased to announce that Dr....

First Medical Food for Dietary Management of PKD Launched

First Medical Food for Dietary Management of PKD Launched

First Medical Food for the Dietary Management of Polycystic Kidney Disease Launched The first-of-its-kind product, named KetoCitraTM, is based on breakthrough research by University of California Santa Barbara professor Dr. Thomas Weimbs, a recognized leader in the...